These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 20080907

  • 1. Tacrolimus, a calcineurin inhibitor, overcomes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis.
    Suzuki K, Saito K, Tsujimura S, Nakayamada S, Yamaoka K, Sawamukai N, Iwata S, Nawata M, Nakano K, Tanaka Y.
    J Rheumatol; 2010 Mar; 37(3):512-20. PubMed ID: 20080907
    [Abstract] [Full Text] [Related]

  • 2. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.
    Tsujimura S, Saito K, Nawata M, Nakayamada S, Tanaka Y.
    Ann Rheum Dis; 2008 Mar; 67(3):380-8. PubMed ID: 17660216
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
    Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T, Rutstein J, Baldassare A, Kaine J, Calabrese L, Dietz F, Sack M, Senter RG, Wiesenhutter C, Schiff M, Stein CM, Satoi Y, Matsumoto A, Caldwell J, Harris RE, Moreland LW, Hurd E, Yocum D, Stamler DA.
    Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.
    Kremer JM, Habros JS, Kolba KS, Kaine JL, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA, Tacrolimus-Methotrexate Rheumatoid Arthritis Study Group.
    Arthritis Rheum; 2003 Oct; 48(10):2763-8. PubMed ID: 14558080
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis.
    Kitahara K, Kawai S.
    Curr Opin Rheumatol; 2007 May; 19(3):238-45. PubMed ID: 17414949
    [Abstract] [Full Text] [Related]

  • 6. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.
    Yocum DE, Furst DE, Bensen WG, Burch FX, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisememandle W, Mekki QA, Tacrolimus RA Study Group.
    Rheumatology (Oxford); 2004 Aug; 43(8):992-9. PubMed ID: 15014199
    [Abstract] [Full Text] [Related]

  • 7. Is steroid resistance related to multidrug resistance-I (MDR-I) in rheumatoid arthritis?
    Borowski LC, Lopes RP, Gonzalez TP, Dummer LA, Chies JA, Silveira IG, Keisermann M, Bauer ME.
    Int Immunopharmacol; 2007 Jun; 7(6):836-44. PubMed ID: 17466917
    [Abstract] [Full Text] [Related]

  • 8. Tacrolimus (FK506) in the treatment of severe, refractory rheumatoid arthritis: initial experience in 12 patients.
    Gremillion RB, Posever JO, Manek N, West JP, van Volen-Hoven RF.
    J Rheumatol; 1999 Nov; 26(11):2332-6. PubMed ID: 10555886
    [Abstract] [Full Text] [Related]

  • 9. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V.
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy of tacrolimus for joint destruction in rheumatoid arthritis].
    Tanaka Y, Suzuki K, Saito K.
    Clin Calcium; 2007 Apr; 17(4):593-9. PubMed ID: 17404490
    [Abstract] [Full Text] [Related]

  • 11. Reversion of resistance to immunosuppressive agents in three patients with psoriatic arthritis by cyclosporine A: modulation of P-glycoprotein function.
    Diamanti AP, Rosado M, Germano V, Scarsella M, Giorda E, Podestà E, D'Amelio R, Carsetti R, Laganà B.
    Clin Immunol; 2011 Jan; 138(1):9-13. PubMed ID: 21062675
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.
    Davis JC, Fessler BJ, Tassiulas IO, McInnes IB, Yarboro CH, Pillemer S, Wilder R, Fleisher TA, Klippel JH, Boumpas DT.
    J Rheumatol; 1998 Sep; 25(9):1694-704. PubMed ID: 9733448
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial.
    Yocum DE, Furst DE, Kaine JL, Baldassare AR, Stevenson JT, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA, Tcrolimus Rheumatoid Arthritis Study Group.
    Arthritis Rheum; 2003 Dec; 48(12):3328-37. PubMed ID: 14673984
    [Abstract] [Full Text] [Related]

  • 19. Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drug.
    Hider SL, Owen A, Hartkoorn R, Khoo S, Back D, Silman AJ, Bruce IN.
    Ann Rheum Dis; 2006 Oct; 65(10):1390-3. PubMed ID: 16504991
    [Abstract] [Full Text] [Related]

  • 20. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M, Zwicker M, Villiger PM.
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.